PARI provides devices and solutions for inhalation for pulmonary, bronchial and also nasopharyngeal diseases. A broad product portfolio offers comprehensive patient care, ranging from diagnosis and treatment to monitoring. PARI works with advanced aerosol delivery platforms.
PARI offers a broad portfolio of specially optimised devices and solutions for inhalation for pulmonary, bronchial and nasopharyngeal diseases, with applications in diagnosis, treatment and monitoring. PARI’s nebulisers and other products are used by millions of patients worldwide and are recognised for their high quality standards.
The PARI business group is headquartered in Starnberg, Germany, with additional German locations in Weilheim (PARItec GmbH, production), Gräfelfing and Gilching (PARI Pharma GmbH, eFlow® Technology and medicinal products). In addition, PARI Respiratory Equipment Inc (Midlothian, VA, US) is the US-based operation. PARI products are distributed via international branch offices and a worldwide distribution network.
PARI Pharma is specialised, based on the eFlow® Technology platform, in developing and manufacturing optimised vibrating membrane nebulisers for advanced aerosol therapies. The company develops combinations of drug product with the device in collaboration pharmaceutical industry partners.
PARI is privately owned. It was originally founded in 1906 in Wuppertal, Germany. Today the company has around 500-600 employees worldwide.